QQQ   431.12 (-1.63%)
AAPL   173.21 (-1.89%)
MSFT   414.71 (-1.70%)
META   499.15 (-2.49%)
GOOGL   155.23 (-1.58%)
AMZN   183.85 (-1.22%)
TSLA   162.64 (-4.92%)
NVDA   867.35 (-1.65%)
AMD   160.50 (-1.70%)
NIO   3.85 (-6.33%)
BABA   70.35 (-1.32%)
T   16.20 (-0.67%)
F   12.24 (-2.93%)
MU   121.10 (-1.16%)
GE   153.13 (-0.97%)
CGC   6.82 (-12.56%)
DIS   113.07 (-0.82%)
AMC   2.51 (-5.28%)
PFE   25.85 (-0.04%)
PYPL   63.46 (-1.75%)
XOM   119.68 (-0.57%)
QQQ   431.12 (-1.63%)
AAPL   173.21 (-1.89%)
MSFT   414.71 (-1.70%)
META   499.15 (-2.49%)
GOOGL   155.23 (-1.58%)
AMZN   183.85 (-1.22%)
TSLA   162.64 (-4.92%)
NVDA   867.35 (-1.65%)
AMD   160.50 (-1.70%)
NIO   3.85 (-6.33%)
BABA   70.35 (-1.32%)
T   16.20 (-0.67%)
F   12.24 (-2.93%)
MU   121.10 (-1.16%)
GE   153.13 (-0.97%)
CGC   6.82 (-12.56%)
DIS   113.07 (-0.82%)
AMC   2.51 (-5.28%)
PFE   25.85 (-0.04%)
PYPL   63.46 (-1.75%)
XOM   119.68 (-0.57%)
QQQ   431.12 (-1.63%)
AAPL   173.21 (-1.89%)
MSFT   414.71 (-1.70%)
META   499.15 (-2.49%)
GOOGL   155.23 (-1.58%)
AMZN   183.85 (-1.22%)
TSLA   162.64 (-4.92%)
NVDA   867.35 (-1.65%)
AMD   160.50 (-1.70%)
NIO   3.85 (-6.33%)
BABA   70.35 (-1.32%)
T   16.20 (-0.67%)
F   12.24 (-2.93%)
MU   121.10 (-1.16%)
GE   153.13 (-0.97%)
CGC   6.82 (-12.56%)
DIS   113.07 (-0.82%)
AMC   2.51 (-5.28%)
PFE   25.85 (-0.04%)
PYPL   63.46 (-1.75%)
XOM   119.68 (-0.57%)
QQQ   431.12 (-1.63%)
AAPL   173.21 (-1.89%)
MSFT   414.71 (-1.70%)
META   499.15 (-2.49%)
GOOGL   155.23 (-1.58%)
AMZN   183.85 (-1.22%)
TSLA   162.64 (-4.92%)
NVDA   867.35 (-1.65%)
AMD   160.50 (-1.70%)
NIO   3.85 (-6.33%)
BABA   70.35 (-1.32%)
T   16.20 (-0.67%)
F   12.24 (-2.93%)
MU   121.10 (-1.16%)
GE   153.13 (-0.97%)
CGC   6.82 (-12.56%)
DIS   113.07 (-0.82%)
AMC   2.51 (-5.28%)
PFE   25.85 (-0.04%)
PYPL   63.46 (-1.75%)
XOM   119.68 (-0.57%)

Terns Pharmaceuticals (TERN) SEC Filings & 10K Form

$4.93
-0.21 (-4.09%)
(As of 02:57 PM ET)

Recent Terns Pharmaceuticals SEC Filings

DateFilerForm TypeView
04/03/2024
7:47 PM
Terns Pharmaceuticals (Issuer)
Vivo Capital Fund VIII, L.P. (Reporting)
Vivo Capital Surplus Fund VIII, L.P. (Reporting)
Vivo Capital VIII, LLC (Reporting)
Vivo Opportunity Fund Holdings, L.P. (Reporting)
Vivo Opportunity, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2024
6:26 PM
Kuriakose Emil (Reporting)
Terns Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/14/2024
3:50 PM
Terns Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/05/2024
5:01 PM
Burroughs Amy L. (Reporting)
Terns Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
5:02 PM
Burroughs Amy L. (Reporting)
Terns Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/14/2024
7:38 PM
Terns Pharmaceuticals (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
Form SC 13G/A
02/14/2024
2:47 PM
Fairmount Funds Management LLC (Filed by)
Terns Pharmaceuticals (Subject)
Form SC 13G/A
02/13/2024
10:44 AM
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
Terns Pharmaceuticals (Subject)
Form SC 13G/A
02/07/2024
3:20 PM
Terns Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/31/2024
1:08 PM
BlackRock Inc. (Filed by)
Terns Pharmaceuticals (Subject)
Form SC 13G
01/25/2024
6:17 PM
Quirk Erin (Reporting)
Terns Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
6:17 PM
Terns Pharmaceuticals (Issuer)
Vignola Mark J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
6:18 PM
Terns Pharmaceuticals (Issuer)
Yoon Seokho Bryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
6:18 PM
Quigley Jill M. (Reporting)
Terns Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2023
5:03 PM
Terns Pharmaceuticals (Issuer)
Vignola Mark J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2023
5:03 PM
Terns Pharmaceuticals (Issuer)
Yoon Seokho Bryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/17/2023
5:10 PM
Quigley Jill M. (Reporting)
Terns Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2023
3:33 PM
Terns Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/10/2023
8:09 AM
FIL Ltd (Filed by)
Terns Pharmaceuticals (Subject)
Form SC 13G/A
06/27/2023
3:32 PM
MILLENNIUM MANAGEMENT LLC (Filed by)
Terns Pharmaceuticals (Subject)
Form SC 13G
06/14/2023
6:01 PM
KINDLER JEFFREY B (Reporting)
Terns Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2023
6:01 PM
Lu Hongbo (Reporting)
Terns Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2023
6:01 PM
GORDON CARL L (Reporting)
Terns Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2023
6:01 PM
FELLOWS DAVID A (Reporting)
Terns Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2023
6:02 PM
Quigley Jill M. (Reporting)
Terns Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2023
6:02 PM
Terns Pharmaceuticals (Issuer)
Tripuraneni Radhika (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2023
6:02 PM
Taylor Ann Elizabeth (Reporting)
Terns Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2023
3:36 PM
Terns Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2023
3:44 PM
Terns Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2023
8:01 AM
Terns Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/15/2023
7:30 AM
Terns Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/28/2023
3:48 PM
Terns Pharmaceuticals (Filer)
Form ARS
04/28/2023
3:25 PM
Terns Pharmaceuticals (Filer)
Form DEF 14A
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:TERN) was last updated on 4/15/2024 by MarketBeat.com Staff

From Our Partners